Lumos Diagnostics Holdings Limited

ASX:LDX Stock Report

Market Cap: AU$22.6m

Lumos Diagnostics Holdings Past Earnings Performance

Past criteria checks 0/6

Lumos Diagnostics Holdings's earnings have been declining at an average annual rate of -18.8%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been declining at an average rate of 20.1% per year.

Key information

-18.8%

Earnings growth rate

32.8%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate-20.1%
Return on equity-95.6%
Net Margin-107.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Take Care Before Diving Into The Deep End On Lumos Diagnostics Holdings Limited (ASX:LDX)

Jan 03
Take Care Before Diving Into The Deep End On Lumos Diagnostics Holdings Limited (ASX:LDX)

The Market Lifts Lumos Diagnostics Holdings Limited (ASX:LDX) Shares 387% But It Can Do More

Jul 04
The Market Lifts Lumos Diagnostics Holdings Limited (ASX:LDX) Shares 387% But It Can Do More

Bearish: Analysts Just Cut Their Lumos Diagnostics Holdings Limited (ASX:LDX) Revenue and EPS estimates

Jul 12
Bearish: Analysts Just Cut Their Lumos Diagnostics Holdings Limited (ASX:LDX) Revenue and EPS estimates

Revenue & Expenses Breakdown
Beta

How Lumos Diagnostics Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:LDX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 238-9110
30 Sep 239-9110
30 Jun 2311-9110
31 Mar 2311-25151
31 Dec 2212-41191
30 Sep 2212-43211
30 Jun 2212-46241
31 Mar 2214-34241
31 Dec 2116-23241
30 Sep 2117-19211
30 Jun 2119-15181
31 Mar 2116-12162
31 Dec 2012-9152
30 Sep 209-9132
30 Jun 206-9112
30 Jun 194-541
30 Jun 182-120

Quality Earnings: LDX is currently unprofitable.

Growing Profit Margin: LDX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: LDX is unprofitable, and losses have increased over the past 5 years at a rate of 18.8% per year.

Accelerating Growth: Unable to compare LDX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LDX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: LDX has a negative Return on Equity (-95.59%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.